Allergan Plc - Product Pipeline Review - 2016

  • ID: 3693090
  • Company Profile
  • 150 pages
  • Global Markets Direct
  • Allergan plc
1 of 4
Allergan Plc - Product Pipeline Review - 2016

Summary

‘Allergan Plc - Product Pipeline Review - 2016’, provides an overview of the Allergan Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Allergan Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Allergan Plc
- The report provides overview of Allergan Plc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Allergan Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Allergan Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Allergan Plc’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Allergan Plc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Allergan Plc’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Allergan Plc Snapshot

Allergan Plc Overview

Key Information

Key Facts

Allergan Plc - Research and Development Overview

Key Therapeutic Areas

Allergan Plc - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Allergan Plc - Pipeline Products Glance

Allergan Plc - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Filing rejected/Withdrawn Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Allergan Plc - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Allergan Plc - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Allergan Plc - Drug Profiles

eluxadoline

Product Description

Mechanism of Action

R&D Progress

(nebivolol + valsartan)

Product Description

Mechanism of Action

R&D Progress

dihydroergotamine mesylate

Product Description

Mechanism of Action

R&D Progress

norethindrone

Product Description

Mechanism of Action

R&D Progress

abicipar pegol

Product Description

Mechanism of Action

R&D Progress

Aczone X

Product Description

Mechanism of Action

R&D Progress

AGN-229666

Product Description

Mechanism of Action

R&D Progress

bimatoprost SR

Product Description

Mechanism of Action

R&D Progress

cariprazine

Product Description

Mechanism of Action

R&D Progress

dalbavancin

Product Description

Mechanism of Action

R&D Progress

desmopressin acetate

Product Description

Mechanism of Action

R&D Progress

onabotulinumtoxin A

Product Description

Mechanism of Action

R&D Progress

oxymetazoline hydrochloride

Product Description

Mechanism of Action

R&D Progress

sarecycline hydrochloride

Product Description

Mechanism of Action

R&D Progress

ulipristal acetate

Product Description

Mechanism of Action

R&D Progress

AGN-195263

Product Description

Mechanism of Action

R&D Progress

AGN-223575

Product Description

Mechanism of Action

R&D Progress

ANT-1207

Product Description

Mechanism of Action

R&D Progress

ANT-1403

Product Description

Mechanism of Action

R&D Progress

brimonidine tartrate implant

Product Description

Mechanism of Action

R&D Progress

cyclosporine

Product Description

Mechanism of Action

R&D Progress

lidocaine hydrochloride

Product Description

Mechanism of Action

R&D Progress

NRX-1074

Product Description

Mechanism of Action

R&D Progress

oxybutynin chloride

Product Description

Mechanism of Action

R&D Progress

rapastinel

Product Description

Mechanism of Action

R&D Progress

ubrogepant

Product Description

Mechanism of Action

R&D Progress

udenafil

Product Description

Mechanism of Action

R&D Progress

AGN-232411

Product Description

Mechanism of Action

R&D Progress

MK-8031

Product Description

Mechanism of Action

R&D Progress

bezafibrate ER

Product Description

Mechanism of Action

R&D Progress

setipiprant

Product Description

Mechanism of Action

R&D Progress

AGN-151200

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Glaucoma

Product Description

Mechanism of Action

R&D Progress

Neurotoxin Program

Product Description

Mechanism of Action

R&D Progress

Recombinant Proteins for Ophthalmology

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit CGRP Receptor for Migraine

Product Description

Mechanism of Action

R&D Progress

Allergan Plc - Pipeline Analysis

Allergan Plc - Pipeline Products by Target

Allergan Plc - Pipeline Products by Route of Administration

Allergan Plc - Pipeline Products by Molecule Type

Allergan Plc - Pipeline Products by Mechanism of Action

Allergan Plc - Recent Pipeline Updates

Allergan Plc - Dormant Projects

Allergan Plc - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

alvameline maleate

dapoxetine hydrochloride

dexamethasone acetate

dexloxiglumide

ME-1036

memantine hydrochloride

neramexane mesylate

NRX-1050

NRX-20xx

onabotulinumtoxin A

radiprodil

Allergan Plc - Company Statement

Allergan Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Allergan Plc, Key Information

Allergan Plc, Key Facts

Allergan Plc - Pipeline by Indication, 2016

Allergan Plc - Pipeline by Stage of Development, 2016

Allergan Plc - Monotherapy Products in Pipeline, 2016

Allergan Plc - Combination Treatment Modalities in Pipeline, 2016

Allergan Plc - Partnered Products in Pipeline, 2016

Allergan Plc - Partnered Products/ Combination Treatment Modalities, 2016

Allergan Plc - Out-Licensed Products in Pipeline, 2016

Allergan Plc - Out-Licensed Products/ Combination Treatment Modalities, 2016

Allergan Plc - Pre-Registration, 2016

Allergan Plc - Filing rejected/Withdrawn, 2016

Allergan Plc - Phase III, 2016

Allergan Plc - Phase II, 2016

Allergan Plc - Phase I, 2016

Allergan Plc - IND/CTA Filed, 2016

Allergan Plc - Preclinical, 2016

Allergan Plc - Discovery, 2016

Allergan Plc - Pipeline by Target, 2016

Allergan Plc - Pipeline by Route of Administration, 2016

Allergan Plc - Pipeline by Molecule Type, 2016

Allergan Plc - Pipeline Products by Mechanism of Action, 2016

Allergan Plc - Recent Pipeline Updates, 2016

Allergan Plc - Dormant Developmental Projects,2016

Allergan Plc - Discontinued Pipeline Products, 2016

Allergan Plc, Subsidiaries

List of Figures

Allergan Plc - Pipeline by Top 10 Indication, 2016

Allergan Plc - Pipeline by Stage of Development, 2016

Allergan Plc - Monotherapy Products in Pipeline, 2016

Allergan Plc - Partnered Products in Pipeline, 2016

Allergan Plc - Out-Licensed Products in Pipeline, 2016

Allergan Plc - Pipeline by Top 10 Target, 2016

Allergan Plc - Pipeline by Top 10 Route of Administration, 2016

Allergan Plc - Pipeline by Molecule Type, 2016

Allergan Plc - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll